HR Execs on the Move

LifeScript

www.lifescript.com

 
LifeScript is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

TechHealth

TechHealth is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foundation Fighting Blindness

The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.

HCA Physician Services Group

The HCA Physician Services Group, a part of the HCA family, is focused on implementing innovative, value-added solutions that help our physicians deliver high quality, cost effective healthcare and support HCA`s commitment to the care and improvement of human life. As the physician solution for HCA, the Physician Services Group makes it easier for physicians to practice medicine by reducing the burdens of managing an independent practice and infusing the best clinical and operational standards in every office. The Physician Services Group is always looking for great people who are passionate about caring for human life. We are looking for experienced health care executives, skilled operators, area and market managers, practice managers, accountants, coders, business analysts, charge entry specialists, medical assistants and all around leaders ready for their next great opportunity.

Premier Health Partners

Premier Health Partners is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.